Cross Country Healthcare revenues fall in Q4
Cross Country Healthcare net loss was $6m, compared to a net income of $398,000 for the same period in 2009. For the full year of 2010, the company
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.